Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty
Clinical trial NCT05558410 · COMPLETED
Trial details
- NCT number
- NCT05558410
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2023-08-25
- Enrollment
- 1118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.